Edwards Lifesciences Corporation
US ˙ NYSE ˙ US28176E1082

SecurityEW / Edwards Lifesciences Corporation
InstitutionPinnacle Bancorp, Inc.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Pinnacle Bancorp, Inc. closes position in EW / Edwards Lifesciences Corporation

On July 11, 2025 - Pinnacle Bancorp, Inc. filed a 13F-HR form disclosing ownership of 0 shares of Edwards Lifesciences Corporation (US:EW) valued at $0 USD as of June 30, 2025. The entity filed a previous 13F-HR on April 23, 2025 disclosing 90 shares of Edwards Lifesciences Corporation. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-07-11 2025-06-30 13F Edwards Lifesciences Corp Com COM 28176E108 0 -90 -100.00 0 -100.00
2025-04-23 2025-03-31 13F Edwards Lifesciences Corp Com COM 28176E108 90 -614 -87.22 7 -88.46 0.0021
2025-01-14 2024-12-31 13F Edwards Lifesciences Corp Com COM 28176E108 704 -123 -14.87 52 -3.70 0.0170
2024-10-09 2024-09-30 13F Edwards Lifesciences Corp Com COM 28176E108 827 0 0.00 55 -28.95 0.0146
2024-07-15 2024-06-30 13F Edwards Lifesciences Corp Com COM 28176E108 827 0 0.00 76 -3.80 0.0226
2024-04-16 2024-03-31 13F Edwards Lifesciences Corp Com COM 28176E108 827 -132 -13.76 79 8.22 0.0234
2024-01-25 2023-12-31 13F Edwards Lifesciences Corp Com COM 28176E108 959 100 11.64 73 23.73 0.0239
2023-10-18 2023-09-30 13F Edwards Lifesciences Corp Com COM 28176E108 859 0 0.00 60 -27.16 0.0212
2023-07-14 2023-06-30 13F Edwards Lifesciences Corp Com COM 28176E108 859 0 0.00 81 14.08 0.0277
2023-04-14 2023-03-31 13F Edwards Lifesciences Corp Com COM 28176E108 859 0 0.00 71 0.0261
2023-01-24 2022-12-31 13F Edwards Lifesciences Corp Com COM 28176E108 859 107 14.23 0 -100.00 0.0246
2022-10-25 2022-09-30 13F Edwards Lifesciences Corp Com COM 28176E108 752 51 7.28 62 -7.46 0.0268
2022-07-12 2022-06-30 13F Edwards Lifesciences Corp Com COM 28176E108 701 0 0.00 67 -19.28 0.0276
2022-04-14 2022-03-31 13F Edwards Lifesciences Corp Com COM 28176E108 701 110 18.61 83 7.79 0.0288
2022-01-19 2021-12-31 13F Edwards Lifesciences Corp Com COM 28176E108 591 -42 -6.64 77 6.94 0.0272
2021-10-12 2021-09-30 13F Edwards Lifesciences Corp Com COM 28176E108 633 -215 -25.35 72 -18.18 0.0288
2021-07-15 2021-06-30 13F Edwards Lifesciences Corp Com COM 28176E108 848 0 0.00 88 23.94 0.0402
2021-04-26 2021-03-31 13F Edwards Lifesciences Corp Com COM 28176E108 848 0 0.00 71 -7.79 0.0344
2021-01-13 2020-12-31 13F Edwards Lifesciences Corp Com COM 28176E108 848 0 0.00 77 13.24 0.0474
2020-10-13 2020-09-30 13F Edwards Lifesciences Corp Com COM 28176E108 848 -553 -39.47 68 -29.90 0.0479
2020-07-07 2020-06-30 13F Edwards Lifesciences Corp Com COM 28176E108 1,401 934 200.00 97 10.23 0.0722
2020-04-09 2020-03-31 13F Edwards Lifesciences Corp Com COM 28176E108 467 41 9.62 88 -11.11 0.0752
2020-01-10 2019-12-31 13F Edwards Lifesciences Corp Com COM 28176E108 426 -29 -6.37 99 -1.00 0.0686
2019-10-08 2019-09-30 13F Edwards Lifesciences Corp Com COM 28176E108 455 29 6.81 100 26.58 0.0571
2019-07-08 2019-06-30 13F Edwards Lifesciences Corp Com COM 28176E108 426 0 0.00 79 -3.66 0.0444
2019-04-05 2019-03-31 13F Edwards Lifesciences Corp Com COM 28176E108 426 0 0.00 82 26.15 0.0476
2019-03-20 2018-12-31 13F Edwards Lifesciences Corp Com COM 28176E108 426 426 65 0.0400
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.